A detailed history of Deseret Mutual Benefit Administrators transactions in Biogen Inc. stock. As of the latest transaction made, Deseret Mutual Benefit Administrators holds 1,525 shares of BIIB stock, worth $227,255. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,525
Previous 1,524 0.07%
Holding current value
$227,255
Previous $353,000 16.43%
% of portfolio
0.15%
Previous 0.16%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$189.07 - $236.8 $189 - $236
1 Added 0.07%
1,525 $295,000
Q2 2024

Aug 02, 2024

BUY
$190.52 - $236.72 $15,051 - $18,700
79 Added 5.47%
1,524 $353,000
Q1 2024

May 09, 2024

BUY
$212.02 - $267.71 $30,318 - $38,282
143 Added 10.98%
1,445 $311,000
Q4 2023

Feb 13, 2024

SELL
$222.59 - $267.94 $88,145 - $106,104
-396 Reduced 23.32%
1,302 $336,000
Q3 2023

Nov 09, 2023

SELL
$253.3 - $285.89 $27,103 - $30,590
-107 Reduced 5.93%
1,698 $436,000
Q2 2023

Aug 07, 2023

BUY
$275.25 - $318.06 $3,853 - $4,452
14 Added 0.78%
1,805 $514,000
Q1 2023

May 09, 2023

BUY
$256.56 - $292.34 $2,822 - $3,215
11 Added 0.62%
1,791 $497,000
Q4 2022

Feb 13, 2023

SELL
$252.44 - $306.72 $258,751 - $314,388
-1,025 Reduced 36.54%
1,780 $492,000
Q3 2022

Nov 03, 2022

SELL
$194.69 - $268.46 $79,238 - $109,263
-407 Reduced 12.67%
2,805 $749,000
Q2 2022

Aug 05, 2022

BUY
$187.54 - $223.02 $54,199 - $64,452
289 Added 9.89%
3,212 $655,000
Q1 2022

May 11, 2022

SELL
$193.77 - $244.14 $46,311 - $58,349
-239 Reduced 7.56%
2,923 $616,000
Q4 2021

Feb 09, 2022

BUY
$223.92 - $287.77 $31,348 - $40,287
140 Added 4.63%
3,162 $759,000
Q3 2021

Nov 04, 2021

BUY
$282.99 - $369.05 $576,167 - $751,385
2,036 Added 206.49%
3,022 $855,000
Q2 2021

Aug 06, 2021

BUY
$259.0 - $414.71 $255,374 - $408,904
986 New
986 $341,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Deseret Mutual Benefit Administrators Portfolio

Follow Deseret Mutual Benefit Administrators and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deseret Mutual Benefit Administrators, based on Form 13F filings with the SEC.

News

Stay updated on Deseret Mutual Benefit Administrators with notifications on news.